Michael Fossel, MD, PhD, a leading expert on the use of telomerase for age-related diseases. He is the founder and president of Telocyte, a company that is investigating telomerase therapy for Alzheimer’s disease. A former professor of clinical medicine at Michigan State University, he is the founder of the scientific journal Rejuvenation Research, and the author of The Telomerase Revolution: The Enzyme That Holds the Key to Human Aging and Will Soon Lead to Longer, Healthier Lives. MichaelFossel.com
The key is not what you expect… When we hear about people who live to age 100 or beyond, it…
